mitoguazone

mitoguazone

A non-myelosuppressing anti-tumour agent, which was once thought useful for managing non-Hodgkin lymphoma. It is no longer under active development.
Adverse effects
Mucosal inflammation, vasculitis, painful skin lesions, anorexia, weight loss, diarrhoea.